Brief: T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale In Company History
30/05/2023 14:02
May 30 (Reuters) - T2 Biosystems Inc TTOO.O :
* T2 BIOSYSTEMS ANNOUNCES SECOND LARGEST SEPSIS-DRIVEN
INSTRUMENT
SALE IN COMPANY HISTORY
* T2 BIOSYSTEMS INC - DISTRIBUTION PARTNER, BIOMEDICA
POLAND,
SECURED MULTI-YEAR CONTRACT FOR T2DX INSTRUMENTS AND SEPSIS TEST
PANELS
* T2 BIOSYSTEMS INC - INITIAL ORDER INCLUDES SEVEN T2DX
INSTRUMENTS, VALUED AT MORE THAN $450,000
* T2 BIOSYSTEMS INC - POTENTIAL FOR 9 ADDITIONAL INSTRUMENTS
TO BE
SOLD AND DEPLOYED INTO AN INCREASED NUMBER OF HOSPITALS IN
POLAND DURING H2 OF 2023
* T2 BIOSYSTEMS INC - INITIAL TERM OF CONTRACT SECURED BY
DISTRIBUTOR IS FOR THREE YEARS, WITH POTENTIAL TO EXTEND FOR AN
ADDITIONAL TWO YEARS
Source text for Eikon: ID:nGNX9VkbfJ
Further company coverage: TTOO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on T2 Biosystems
See all newsBrief: T2 Biosystems Announces Intent To Wind Down Operations
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor